| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Canada | 1 | |
| #5 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kohler Heinz | 11 |
| #2 | Muller Sybille | 8 |
| #3 | Morgan Alton Charles Jr | 4 |
| #4 | Brown Thomas L | 2 |
| #5 | Zhao Yunfeng | 2 |
| #6 | Russ Michael A | 1 |
| #7 | Morgan Alton C Jr | 1 |
| #8 | Morgan Jr A Charles | 1 |
| #9 | Morgan Jr Alton C | 1 |
| #10 | Amick Jean Davin | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2010017898A1 | Therapeutic applications of noncovalent dimerizing antibodies | |
| US2009274710A1 | Trans-membrane-antibody induced inhibition of apoptosis | |
| US2009075339A1 | Autophilic antibodies | |
| US2005287154A1 | Autophilic antibodies | |
| WO2004078146A2 | Trans-membrane-antibody induced inhibition of apoptosis | |
| EP1017725A1 | Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |